ARRDC3 and neoplasm: In more recent work, we found that loss of ARRDC3 expression is also responsible for defective PAR1 trafficking in invasive breast cancer [79], suggesting that ARRDC3 tumor suppressor function is linked to both integrin β4 and GPCR trafficking.